| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..105.5471O |
| P356 | DOI | 10.1073/PNAS.0800578105 |
| P932 | PMC publication ID | 2291139 |
| P698 | PubMed publication ID | 18367670 |
| P5875 | ResearchGate publication ID | 5484203 |
| P50 | author | Lisa K Gilliam | Q114431955 |
| Christiane S Hampe | Q44927527 | ||
| Mona Landin-Olsson | Q46942445 | ||
| Ingrid Kockum | Q55446225 | ||
| P2093 | author name string | Merrill J Rowley | |
| J Paul Banga | |||
| Michael R Christie | |||
| Shilpa Oak | |||
| Carina Törn | |||
| Christina R Pennington | |||
| P2860 | cites work | Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies | Q31040277 |
| Towards a network theory of the immune system. | Q34202813 | ||
| Perpetuation of immunological memory: a relay hypothesis | Q34235888 | ||
| Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin | Q34362734 | ||
| Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes | Q34512616 | ||
| Development of type 1 diabetes despite severe hereditary B-cell deficiency | Q74593633 | ||
| The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies | Q75217669 | ||
| Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children | Q77619587 | ||
| Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs | Q79207765 | ||
| Multiplicity of the antibody response to GAD65 in Type I diabetes | Q80892738 | ||
| Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes | Q81657563 | ||
| Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 | ||
| Autoantibodies in autoimmune polyendocrine syndrome type II. | Q34715410 | ||
| Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics | Q35649417 | ||
| Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance | Q35745247 | ||
| Diabetes-related antibodies in adult diabetic patients | Q36096638 | ||
| Facing the enigma of immunomodulatory effects of intravenous immunoglobulin | Q36359673 | ||
| Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model | Q36371477 | ||
| Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus | Q36708258 | ||
| Immunoglobulin E blockade in the treatment of asthma | Q36951998 | ||
| Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults | Q37387240 | ||
| Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient | Q40607014 | ||
| Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope | Q40720812 | ||
| Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes | Q44191950 | ||
| IgG auto-anti-idiotype antibodies against antibody to insulin in insulin-dependent (type 1) diabetes mellitus. Detection by capture enzyme linked immunosorbent assay (ELISA) and relationship with anti-insulin antibody levels | Q44489482 | ||
| GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. | Q44876645 | ||
| Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers | Q45087522 | ||
| Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients | Q46815045 | ||
| A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. | Q51542822 | ||
| Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor. | Q51642495 | ||
| Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. | Q52348002 | ||
| Unmasking of anti-ribosomal P autoantibodies in healthy individuals | Q52509111 | ||
| COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity | Q57079408 | ||
| Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy | Q57499724 | ||
| Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients | Q59071320 | ||
| Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies | Q59829524 | ||
| Idiotypic-antiidiotypic interactions in man | Q67285035 | ||
| Insulin-mimicking anti-idiotypic antibodies in development of spontaneous autoimmune diabetes in BB/E rats | Q68611947 | ||
| Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin | Q70991907 | ||
| Auto-anti-anti-DNA antibodies from SLE patients and normals | Q71010766 | ||
| Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies | Q71150178 | ||
| Receptor-like activity of a monoclonal anti-idiotypic antibody against an anti-acetylcholine receptor antibody | Q71372296 | ||
| Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response | Q73738496 | ||
| High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry | Q73857667 | ||
| The presence of masked antiribosomal P autoantibodies in healthy children | Q74060189 | ||
| Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects | Q74529894 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| autoantibody | Q785022 | ||
| type-1 diabetes | Q124407 | ||
| P304 | page(s) | 5471-5476 | |
| P577 | publication date | 2008-03-26 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes | |
| P478 | volume | 105 |
| Q34182775 | Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse |
| Q34347058 | Anti-idiotypic monobodies for immune response profiling |
| Q41751849 | Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes |
| Q36551060 | Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. |
| Q82269020 | Autoimmunity: increasing suspects in the CD4+ T cell lineup |
| Q33593017 | B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody. |
| Q33750667 | Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes |
| Q34262463 | Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity |
| Q37482636 | Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies |
| Q40070247 | DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes |
| Q34778635 | Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes |
| Q33358948 | Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus |
| Q45820463 | Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes. |
| Q37358994 | GAD65 autoimmunity-clinical studies. |
| Q90401543 | Immune Response Regulation by Antigen Receptors' Clone-Specific Nonself Parts |
| Q33384840 | Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies |
| Q37373912 | Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals |
| Q38156224 | Immunology of stiff person syndrome and other GAD-associated neurological disorders |
| Q34630695 | Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects |
| Q33682376 | Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes |
| Q84510281 | Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals |
| Q38097613 | On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development? |
| Q45942661 | Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies. |
| Q37656095 | Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes |
| Q26864907 | Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies |
| Q92544156 | Serum C-peptide and osteocalcin levels in children with recently diagnosed diabetes |
| Q35581618 | Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes |
| Q39017503 | Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. |
| Q45951645 | T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. |
| Q41648531 | Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells |
| Q82468670 | The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation |
| Q47577827 | The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes |
| Q34110768 | The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions |
| Q28295552 | The immunological basis for treatment of stiff person syndrome |
| Q38132851 | The preventive role of type 2 NKT cells in the development of type 1 diabetes |
| Q35004343 | Vaccination against type 1 diabetes |
| Q37520312 | ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset |
Search more.